Full text is available at the source.
Abstract
ALSF, a novel lipid nanoparticle, enabled effective co-delivery of GPX4-siRNA and Fe3+ for cancer treatment.
- The lipid nanoparticle replaces DSPC with arachidonic acid to facilitate simultaneous delivery.
- ALSF promotes acid- and H2O2-dependent iron recycling to generate Fe2+, enhancing reactive oxygen species production.
- Silencing of GPX4 by siRNA leads to increased lipid peroxidation and induction of ferroptosis.
- Elevated H2O2 levels in cancer cells enhance iron recycling and aid in siRNA escape from lysosomes.
- In vivo experiments showed that ALSF suppressed tumor growth in a C918 xenograft model while demonstrating favorable biosafety.
Simplified